$1259 Kowa TSN-553 Prominar Pure Fluorite Spotting Scope Sports Outdoors Sports Fitness Hunting Fishing Kowa TSN-553 High quality Prominar Pure Scope Fluorite Spotting $1259 Kowa TSN-553 Prominar Pure Fluorite Spotting Scope Sports Outdoors Sports Fitness Hunting Fishing $1259,Sports Outdoors , Sports Fitness , Hunting Fishing,/gynaecea705522.html,gwptck.ac.in,Spotting,Kowa,Prominar,Fluorite,TSN-553,Scope,Pure Kowa TSN-553 High quality Prominar Pure Scope Fluorite Spotting $1259,Sports Outdoors , Sports Fitness , Hunting Fishing,/gynaecea705522.html,gwptck.ac.in,Spotting,Kowa,Prominar,Fluorite,TSN-553,Scope,Pure

Kowa TSN-553 High quality Prominar 35% OFF Pure Scope Fluorite Spotting

Kowa TSN-553 Prominar Pure Fluorite Spotting Scope

$1259

Kowa TSN-553 Prominar Pure Fluorite Spotting Scope

|||

From the brand

Kowa Sporting OpticsKowa Sporting Optics
Kowa Sporting OpticsKowa Sporting Optics
KOWA SPORTING OPTICS - OVER 60 YEARS OF OPTICAL EXCELLENCE

Our story


How we got our start?
From the invention of the original spotting scope in the 1950s, every decade has seen Japanese optics manufacturer Kowa continue to innovate. This legacy continues today with one of the largest and finest ranges of spotting scopes, over 20 binocular models and digiscoping adapters and accessories.
What makes our product unique?
Kowa are the only spotting scope manufacturer to use pure fluorite crystal lenses in their flagship TSN-880 and TSN-550 spotting scopes - fluorite crystal delivers an outstanding view of the natural world and takes delicate and complex manufacturing techniques - it’s what makes Kowa optics unique.
Why we love what we do?
Kowa manufacture optical instruments to view the beauty of our natural world - a world that Kowa want to protect for future generations. As a responsible optics manufacturer, Kowa leads the way by example throughout the manufacturing process focusing on environmental safety and energy conservation.

Product Description

Kowa forged a major statement in the world of sporting optics with the launch of the legendary Kowa TSN-880 Prominar series spotting scopes. A fluorite crystal spotting scope matched by no other on the market. To this day, the Kowa TSN-880 Prominar remains at the pinnacle of optical performance. The TSN-550 Prominar follows in the footsteps of this legendary optic and once again set's the benchmark in spotting scopes in the compact market. Not only does the TSN-550 Prominar adopt the unique styling of it's larger TSN-880 predecessor, it also inherits what makes the TSN-880 still unrivaled to this day - decades of Kowa optical development. Kowa's dream was to create and ultra-portable spotting scope delivering the highest levels of optical performance. This vision has been realized in the TSN-550 Prominar. The 55 mm. features a 15-45x zoom eyepiece, a dual focus system for better focus at higher magnification, and with it weighing less than two pounds, it is ultra-lightweight and easy to pack and carry. The objective lens is pure fluorite crystal that has ultra-low dispersion properties not possessed by ordinary optical glass. This outstanding specification adds the featured benefit of a near-completely reduction in chromatic aberration to provide users with the ultimate viewing experience. Also, all of the lenses are fully, multi-coated. The field of view ranges from 132 ft. at 15x and 69 ft. at full, 45x zoom. Minimum focusing distance is 9.8 ft. at 15x. Eye relief is 14 - 12.5 mm.The TSN-550 series also has a sun shade and twist-up eyecup that allows for easy viewing even when wearing eyeglasses. The TSN-550 series is waterproof and fogproof to JIS Protection Class 7 and filled with dry nitrogen gas to prevent internal fogging. Includes objective and eyepiece covers and cleaning cloth. Additional accessories sold separately.

Kowa TSN-553 Prominar Pure Fluorite Spotting Scope

CURRENT ISSUE
September, 2021

No. 106 (9)

2020 Impact Factor: 9.941 Submission > Acceptance: 52 days
ARTICLES IN THREE SENTENCES
Article

Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

This open-label, single-arm study investigated the long-term efficacy of tafasitamab plus lenalidomide in 81 patients with relapsed/refractory diffuse large B-cell lymphoma. The response rate was 57.5%, including complete responses in 40.0% of patients, and the median duration of response was 43.9 months. This treatment is a valuable option for patients not eligible for autologous stem-cell transplantation.

Johannes Duell et al.

Case Report

Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients

Grey zone lymphoma is a B-cell lymphoma, unclassifiable, with features intermediate between those of large B-cell lymphoma and classic Hodgkin lymphoma. The in-depth study of the two adolescent patients described in this case report expands the clinicopathological and genomic spectrum of this rare pediatric disease. Moreover, it provides information on their response to treatment.

Cagla Y. Benkli et al.

Article

CAMT-MPL: congenital amegakaryocytic thrombocytopenia caused by MPL mutations - heterogeneity of a monogenic disorder - a comprehensive analysis of 56 patients

The clinical picture of 56 patients with congenital amegakaryocytic thrombocytopenia due to MPL mutations was much more varied than previously thought. Twenty-five per cent of them had no signs of thrombocytopenia at birth, and 50% had non-hematologic defects. Pancytopenia developed in (nearly) all patients and hematopoietic stem-cell transplantation was effective in 87% of cases.

Manuela Germeshausen et al.

Article

Oxidative stress activates red cell adhesion to laminin in sickle cell disease

Sickle red blood cells exhibit abnormal adhesion to laminin mediated by Lu/BCAM protein at their surface. This study provides evidence of the involvement of oxidative stress in post-translational modifications of Lu/BCAM which impact the protein’s distribution and cis-interaction with glycophorin C at the cell surface activating its adhesive function in dense sickle red cells. The authors speculate that antioxidant drugs might attenuate this phenomenon.

Maria Alejandra Lizarralde-Iragorri et al.

TAKE ADVANTAGE FROM HAEMATOLOGICA